Regulatory Excellence With over two decades serving pharma, biotech, and medical device clients across US and EU regulators, 3D Communications has deep regulatory storytelling and market access capabilities. This creates an opportunity to offer end-to-end regulatory submissions messaging, payer communications, and key opinion leader/investor engagement services for clients planning regulatory filings and market access strategies.

Integrated Communications 3D's multidisciplinary team—science, regulatory, and market access—coupled with the 3D ACT process and advanced technology enables integrated offerings from scientific storytelling to regulatory strategy and stakeholder engagement. This positions 3D to cross-sell a unified service package to pharma clients seeking to streamline high-stakes communications.

Mid Market Opportunity The revenue range and mid-sized employee base suggest a solid base of mid-market pharma/biotech clients with sizable budgets for strategy, messaging, and digital assets. There is a clear opportunity to upsell ongoing advisory, expanded market access work, and long-term content production such as presentations, regulatory dossiers, and investor materials.

Digital Asset Capabilities The tech stack indicates capacity to produce and host compliant digital content, engaging presentations, and optimized web assets for regulatory and payor audiences. Sales teams can pitch digital asset production, regulatory-compliant marketing materials, and ongoing content maintenance as a recurring revenue stream.

Global Expansion Headquartered on the East Coast with a focus on US and EU markets suggests potential to expand geographic reach or partner with global networks to cross-sell to European biopharma and multinational device companies. Opportunities exist to collaborate with CROs, consulting firms, or KOL networks to broaden channel reach.